Certified by Founder Lodge
Ceretype Neuromedicine, Inc.
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $0
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable ins
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 05 ,2024 | Seed | Undisclosed Amount |
Leafy Tunnel
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
Atlas Invest | $25,000,000 | (Jan 22, 2026)
